Collection of biological samples from patients with pelvic gynecological cancer and endometriosis
Cohort of Patients With Pelvic Gynecological Cancer: Constitution of a Collection of Biological Samples With Radioclinical Characterization
This study is collecting samples from patients with pelvic gynecological cancers and endometriosis to see if they can find clues that help predict cancer recurrence and improve personalized treatments.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Centre Hospitalier Intercommunal Creteil Academic / other |
| Locations | 2 sites (Créteil and 1 other locations) |
| Trial ID | NCT03622983 on ClinicalTrials.gov |
What this trial studies
This study aims to collect biological samples and detailed clinical data from patients diagnosed with pelvic gynecological cancers and endometriosis. By analyzing these samples, researchers hope to identify factors that predict cancer recurrence and develop personalized treatment strategies based on the biological characteristics of the tumors. The study focuses on the evolving biology of pelvic cancers and the potential for personalized medicine, particularly in relation to anti-PARP therapy for ovarian cancer. The findings could enhance understanding and management of these conditions.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older with a diagnosis of pelvic gynecological cancer or endometriosis.
Not a fit: Patients who refuse to participate or are not affiliated with the general social security scheme may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more effective, personalized treatment options for patients with pelvic gynecological cancers and endometriosis.
How similar studies have performed: Other studies have shown promising results in identifying predictive factors for recurrence in similar conditions, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of pelvic gynecological cancer posed on initial histological analysis or during recurrence; * Or diagnosis of endometriosis on histology or imaging * Age ≥ 18 years; * Affiliation to the general social security scheme; * Consent signed. Exclusion Criteria: * Refusal of the patient; * Non-affiliation to the general social security scheme.
Where this trial is running
Créteil and 1 other locations
- CHI Creteil — Créteil, France (Recruiting)
- CHU Tenon — Paris, France (Recruiting)
Study contacts
- Study coordinator: Cyril Touboul
- Email: cyril.touboul@gmail.com
- Phone: 0156017000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.